Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 24, 2017
Pharmacy Choice - News - Front Page Healthcare News - March 24, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

3/24/17 - "Fast Acting Orally Disintegrating Film" in Patent Application Approval Process (USPTO 20170056374)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Lee, Catherine; Wang, Chien-Chiao, filed on November 14, 2016, was made available online on March 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to TAHO Pharmaceuticals Ltd.
3/24/17 - "New England Journal of Medicine" publishes long-term results of Gleevec for patients with chronic myeloid leukemia
By a News Reporter-Staff News Editor at Drug Week- In 2001 the U.S. Food and Drug Administration granted priority review for imatinib mesylate, sold under the name Gleevec *, as an oral therapy for patients with chronic myeloid leukemia, or CML. According to the HYPERLINK " https://www.cancer.gov/research/progress/discovery/gleevec"\ nNational
3/24/17 - AARP: Repealing Obamacare would hurt Hawaii's seniors
AARP, a nonprofit, nonpartisan, social welfare organization, released a scathing assessment of the Republican-proposed health care bill that's facing opposition from not only Democrats but a segment of the GOP in the U.S. House of Representatives. AARP is strongly against the age tax and other aspects of the bill that will give tax breaks to drug c
3/24/17 - Ablation Devices Global Market - Forecast to 2023 - Driven by Increasing Number of Ablation Procedures & Rising Incidence of Cancer - Research and Markets
Research and Markets has announced the addition of the "Ablation Devices Global Market- Forecast to 2023" report to their offering. The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023.. Abbott Laboratories Access Point Technologies Accuray Aishen Medical Technologies Alcon Research Alma
3/24/17 - Advanced ICU Care Expands Midtown Manhattan Tele-ICU Care Center
By a News Reporter-Staff News Editor at Health& Medicine Week Advanced ICU Care, the nation's leading provider of high-acuity telehealth services, announced a significant expansion of its existing tele-ICU care center in New York City. As one of its eight locations, Advanced ICU Care's midtown Manhattan tele-ICU care center represents a critical
3/24/17 - Affordable Care Act's supporters rally outside Federal Courthouse [Journal Star, Peoria, Ill.]
March 24 PEORIA Supporters of the Affordable Care Act solemnly celebrated the seventh anniversary of signing the it into law with a cold Downtown rally as the future of the health care law was yet to be decided by a divided Congress. Less than an hour after news broke that the House would not take up a vote Thursday on the American Health Care
3/24/17 - Alcon receives US FDA approval for new AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS design for uncompromised distance vision and presbyopia correction
Release date- 23032017- Basel- Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for patients undergoing cataract surgery who choose to address their astigmatism and presbyopi
3/24/17 - Alcon receives US FDA approval for new AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction [Kabulpress.org]
-The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses. Basel, March 23, 2017- Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration f
3/24/17 - American Diabetes Association Urges Opposition to the American Health Care Act
ARLINGTON, Va., March 24, 2017/ PRNewswire-USNewswire/ As the U.S. House of Representatives prepares to vote today on the American Health Care Act, legislation to repeal and replace the Patient Protection and Affordable Care Act, the American Diabetes Association expresses continued concerns with the bill and urges all members of Congress to oppo
3/24/17 - An Obamacare celebration chilled by its uncertain future [Journal Star, Peoria, Ill.]
March 24 PEORIA Supporters of the Affordable Care Act solemnly celebrated the seventh anniversary of signing the it into law with a cold Downtown rally as the future of the health care law was yet to be decided by a divided Congress. Less than an hour after news broke that the House would not take up a vote Thursday on the American Health Care
3/24/17 - APOLLO ENDOSURGERY, INC. - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Our actual results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those set forth under "Risk Factors" and elsewhere in this Annual Report on Form 10- K and those discussed in other documents we file with the SEC. Recent Developments On December 29, 2016, we completed
3/24/17 - Argenx and Broteio Pharma partner to develop antibody for autoimmune diseases [Sudan Tribune]
Netherlands- based biotechnology company argenx and Broteio Pharma, a joint venture between Prothix and Bioceros, have agreed to partner for the development of a therapeutic antibody for severe autoimmune diseases. The antibody will be developed against a novel target in the complement cascade with therapeutic potential in auto-antibody-mediated an
3/24/17 - As GOP dissent grows, U.S. Rep. Shimkus says party 'on a rescue mission' for health care [Chicago Tribune]
March 23 Amid growing dissent from Republicans on their health care overhaul, U.S. Rep. Shimkus, the longest-serving GOP member of Congress from Illinois, criticized the 2010 Affordable Care Act for failing to let all Americans keep their insurance plan and doctor and enjoy lower health care costs. Some of the state's seven Republican members sup
3/24/17 - As Trump says 'do or die' on health act, restaurants face extreme consequences
When President Donald Trump issued an ultimatum Thursday to Congress forcing them to vote on his replacement proposal for the Affordable Care Act, it became evident that a decision on this game-changing legislation will be made some time today. "It is estimated that 10 million restaurant workers or roughly 68 percent of all restaurant workers
3/24/17 - AveXis Reports Topline Results from Phase 1 Trial of SMA Type 1 Gene Therapy [Syrian Arab News Agency]
AveXis, a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, reported topline results from the Phase 1 trial of AVXS-101 in spinal muscular atrophy Type 1. The completion of our Phase 1 clinical study of AVXS-101, the first ever gene therapy studied for the.
3/24/17 - Avita Medical to Present at Needham Healthcare Conference
VALENCIA, Calif.& PERTH, Australia& LONDON Avita Medical Limited, a regenerative medicine company focused on the treatment of wounds and skin defects, today announced that Adam Kelliher, Avita s Chief Executive Officer will present at the 16th Annual Needham Healthcare Conference on 4 April 2017. The presentation will take place at 9:20am ET
3/24/17 - Bharat Book Bureau: Infectious Disease Drugs: The Chinese Market
The Chinese infectious disease drug market is big, fast-growing and dominated by brands from outside China. This market is very important for pharmaceutical companies in North America, Europe and other developed regions that look for strong growth and high profits in the following decade. The goal of this study is to help readers achieve a comprehe
3/24/17 - Biogaran takes over Swipha's activities in Nigeria to produce quality generic medicines for the local market
LAGOS, Nigeria Biogaran, a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier, today announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality. This is an important step forward in the...
3/24/17 - Biogaran takes over Swipha's activities in Nigeria to produce quality generic medicines for the local market A strong commitment to make quality, accessible, affordable medicines available to patients
Biogaran, a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier, today announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality. This is an important step forward in the internationalization of t
3/24/17 - Bioinformatics Market Is Expected To Growing At An Estimated CAGR of 21.2% From 2014 To 2020: Grand View Research, Inc.
According to new report by Grand View Research, The Global bioinformatics market size was valued at USD 3.51 billion in 2013. Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market. The global bioinformatics market is expected to reach USD 13.47 billion
3/24/17 - BioSig Technologies Announces Collaboration with Mayo Clinic Physician Team - Corrected Version [T-break Tech (Middle East)]
BioSig Technologies, Inc., a medical device company developing the PURE EP (TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology marketplace, today announced it has signed an agreement with a team of Mayo Clinic physicians. This new, expanded collaboration builds upon the work realized
3/24/17 - Biothera Pharmaceuticals Phase 2 Study of Imprime PGG Combination Therapy inNon-Small Cell Lung Cancer Patients Published in Investigational New Drugs
Biothera Pharmaceuticals, Inc. today announced peer-reviewed publication of results of a randomized Phase 2 clinical study of the Company s cancer immunotherapy Imprime PGG in combination with Erbitux and chemotherapy in metastatic non-small cell lung cancer patients. Completed by Biothera in 2013, the study was part of an early series of c
3/24/17 - BK Ultrasound, Powered by Analogic, Introduces bkFusion at EAU 2017 [Sudan Tribune]
-Analogic Corporation, enabling the world`s medical imaging and aviation security technology, today announced that it will introduce bkFusion, a groundbreaking solution for improving biopsy targeting in prostate cancer, at the 32nd Annual EAU Congress, March 2427 in London. bkFusion is the latest innovation from the companys flagship BK Ultrasound
3/24/17 - Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology
LONDON, UK/ ACCESSWIRE/ March 24, 2017/ Active Wall St. blog coverage looks at the headline from Egalet Corp. as the Company announced on March 23, 2017, that it has received new US and international patents for the Company's proprietary Guardian? Technology. One of Egalet's competitors within the Biotechnology space, ACADIA Pharmaceuticals Inc.,
3/24/17 - Brady Speaks in Support of the American Health Care Act on the House Floor
EMILY SCHILLINGER, LAUREN ARONSON 226-4774. WASHINGTON, D.C.- House Ways and Means Committee Chairman Kevin Brady today delivered the following remarks on the House floor in support of the American Health Care Act. "Last month, President Trump stood right here in this room and said to Congress:' Obamacare is collapsing.' He called on us to take de
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415